{
  "company": {
    "name": "Frontier Bio",
    "website": "https://frontierbio.com/",
    "record": "https://startuphistory.org/c/frontierbio.com"
  },
  "status": null,
  "history_since": "2020-05-14T05:48:38.000Z",
  "baseline": {
    "snapshot_id": "4e255ebfb530f4370270695d996daca41713085d02b1caa25def012e23b43001",
    "observed_at": "2020-05-14T05:48:38.000Z",
    "headline": "Implantable Tissues",
    "description": "Frontier Bio | Advanced 3D Bioprinting for Revolutionizing Tissue Engineering and Regenerative Medicine",
    "evidence": "https://web.archive.org/web/20200514054838/https://www.frontierbio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:03:29.805Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2020-05-14T05:48:38.000Z",
      "variants": [
        {
          "headline": "Implantable Tissues",
          "subhead": "Frontier Bio | Advanced 3D Bioprinting for Revolutionizing Tissue Engineering and Regenerative Medicine",
          "observed_at": "2020-05-14T05:48:38.000Z",
          "evidence": "https://web.archive.org/web/20200514054838/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Implantable Tissues",
      "subhead": "Frontier Bio | Advanced 3D Bioprinting for Revolutionizing Tissue Engineering and Regenerative Medicine",
      "from": "2020-05-14T05:48:38.000Z",
      "to": "2020-05-14T05:48:38.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20200514054838/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2020-05-14T05:48:38.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-08-18T23:50:41.000Z",
      "variants": [
        {
          "headline": "Engineering the Future of Manufactured Tissue",
          "subhead": null,
          "observed_at": "2021-01-26T21:43:34.000Z",
          "evidence": "https://web.archive.org/web/20210126214334/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Future of Engineered Tissue",
          "subhead": null,
          "observed_at": "2022-08-18T23:50:41.000Z",
          "evidence": "https://web.archive.org/web/20220818235041/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "The Future of Engineered Tissue",
      "subhead": null,
      "from": "2021-01-26T21:43:34.000Z",
      "to": "2022-08-18T23:50:41.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20220818235041/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-01-26T21:43:34.000Z",
          "to": "2022-08-18T23:50:41.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-07-24T03:44:11.000Z",
      "variants": [
        {
          "headline": "Frontier Bio | Engineered Tissues",
          "subhead": "Frontier Bio creates engineered tissues to disrupt animal testing and save patient's lives using cutting-edge 3D bioprinting, organ-on-a-chip, and advanced tissue engineering technology.",
          "observed_at": "2023-09-23T21:57:44.000Z",
          "evidence": "https://web.archive.org/web/20230923215744/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Frontier Bio | Engineered Tissues for Animal-Free Testing",
          "subhead": "Frontier Bio creates engineered tissues to disrupt animal testing and save patient's lives using cutting-edge 3D bioprinting, organ-on-a-chip, and advanced tissue engineering technology. We're revolut",
          "observed_at": "2024-07-24T03:44:11.000Z",
          "evidence": "https://web.archive.org/web/20240724034411/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Frontier Bio | Engineered Tissues for Animal-Free Testing",
      "subhead": "Frontier Bio creates engineered tissues to disrupt animal testing and save patient's lives using cutting-edge 3D bioprinting, organ-on-a-chip, and advanced tissue engineering technology. We're revolut",
      "from": "2023-09-23T21:57:44.000Z",
      "to": "2024-07-24T03:44:11.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20240724034411/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-09-23T21:57:44.000Z",
          "to": "2024-07-24T03:44:11.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-07-22T18:46:16.000Z",
      "variants": [
        {
          "headline": "TOWARDS ON-DEMAND HUMAN TISSUES",
          "subhead": "Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.",
          "observed_at": "2026-07-22T18:46:16.000Z",
          "evidence": "https://web.archive.org/web/20260722184616/https://www.frontierbio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "TOWARDS ON-DEMAND HUMAN TISSUES",
      "subhead": "Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.",
      "from": "2026-07-22T18:46:16.000Z",
      "to": "2026-07-22T18:46:16.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20260722184616/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2026-07-22T18:46:16.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:03:29.805Z",
      "variants": [
        {
          "headline": "A Living Vascular Graft",
          "subhead": "Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.",
          "observed_at": "2026-11-06T17:03:29.805Z",
          "evidence": "https://www.frontierbio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "A Living Vascular Graft",
      "subhead": "Frontier Bio develops living vascular grafts and in-vitro tissue platforms, building the foundation for organ-scale engineered tissues.",
      "from": "2026-11-06T17:03:29.805Z",
      "to": "2026-11-06T17:03:29.805Z",
      "captures": 1,
      "evidence": "https://www.frontierbio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T17:03:29.805Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-4e255ebfb530f4370270695d996daca41713085d02b1caa25def012e23b43001:773ae0c08728b7f71e9b6e7f176fd26c417762c5ed2fa8172a4350d7d74dd15f:headline:bef16f4109ed29e8",
      "before_evidence": "https://web.archive.org/web/20200514054838/https://www.frontierbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Implantable Tissues” to “Engineering the Future of Manufactured Tissue”.",
      "between": {
        "from": "2020-05-14T05:48:38.000Z",
        "to": "2021-01-26T21:43:34.000Z"
      },
      "evidence": "https://web.archive.org/web/20210126214334/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-bfac42e91470eae39625eb7ff4da8a68c2d037e19652a1f038a4258fd8ec92cc:86be5b7430e584132e38c628f71684125ee26bd8229540ec5c42e43d833e2ea1:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20220818235041/https://www.frontierbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2022-08-18T23:50:41.000Z",
        "to": "2023-09-23T21:57:44.000Z"
      },
      "evidence": "https://web.archive.org/web/20230923215744/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 3,
      "id": "page-bfac42e91470eae39625eb7ff4da8a68c2d037e19652a1f038a4258fd8ec92cc:86be5b7430e584132e38c628f71684125ee26bd8229540ec5c42e43d833e2ea1:investors:5fa3b445d7eaa579",
      "before_evidence": "https://web.archive.org/web/20220818235041/https://www.frontierbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: NSF SBIR, Intuitive Surgical, Mayo Clinic, Stanford University, Duke University, NSF, Wellcome Leap and Autodesk.",
      "between": {
        "from": "2022-08-18T23:50:41.000Z",
        "to": "2023-09-23T21:57:44.000Z"
      },
      "evidence": "https://web.archive.org/web/20230923215744/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 4,
      "id": "page-bf9671f0ca69b0404f5cdfceaac8c90f53d15fc1769c3cb38fe4224ba732485a:1d16258bd528fb49222a6b8cd14c8c76226569b47ae790840981b8acce47965e:headline:172419e2ae666040",
      "before_evidence": "https://web.archive.org/web/20250716181952/https://www.frontierbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Connect with Us” to “TOWARDS ON-DEMAND HUMAN TISSUES”.",
      "between": {
        "from": "2025-07-16T18:19:52.000Z",
        "to": "2026-07-22T18:46:16.000Z"
      },
      "evidence": "https://web.archive.org/web/20260722184616/https://www.frontierbio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 5,
      "id": "page-1d16258bd528fb49222a6b8cd14c8c76226569b47ae790840981b8acce47965e:9cebeeef8673e792fa24731eec710e2e422a99e8b5c9781bbc24847b19d54312:headline:d36d29b515180e0a",
      "before_evidence": "https://web.archive.org/web/20260722184616/https://www.frontierbio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “TOWARDS ON-DEMAND HUMAN TISSUES” to “A Living Vascular Graft”.",
      "between": {
        "from": "2026-07-22T18:46:16.000Z",
        "to": "2026-11-06T17:03:29.805Z"
      },
      "evidence": "https://www.frontierbio.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Frontier Bio” company record, https://startuphistory.org/c/frontierbio.com"
}